Subramaniam, Vinod

English

University of Twente Research Information

Biophysics of protein misfolding

NARCIS 

1994.The ability of amyloid beta-protein [A beta P (1-40)] to form Ca2+ channels provides a mechanism for neuronal death in Alzheimer's disease.

1997.The structure of amyloid fibrils by electron microscopy and X-ray diffraction.

2002.The effect of macromolecular crowding agents on alpha-synuclein fibrillation.

2002.Vesicle permeabilization by protofibrillar alpha-synuclein is sensitive to Parkinson's disease-linked mutations and occurs by a pore-like mechanism.

Abeta42-peptide assembly on lipid bilayers.

Accelerated alpha-synuclein fibrillation in crowded milieu.

Accelerated oligomerization by Parkinson's disease linked alpha-synuclein mutants.

Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease.

Alpha-synuclein and neurodegenerative diseases.

Alpha-synuclein and Parkinson's disease.

Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models.

Alpha-synuclein cooperates with CSPalpha in preventing neurodegeneration.

Alpha-synuclein dysfunction in Lewy body diseases.

alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies.

Alpha-synuclein in Lewy bodies.

Alpha-synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils.

Alzheimer's disease and Parkinson's disease.

Amyloid fibril formation by an SH3 domain.

Amyloid fibrils from muscle myoglobin.

Amyloid fibrils from the mammalian protein prothymosin alpha.

Amyloid ion channels: a common structural link for proteinmisfolding disease.

Amyloid-beta peptide assembly: a critical step in fibrillogenesis and membrane disruption.

Annular alpha-synuclein oligomers are potentially toxic agents in alpha-synucleinopathy.

Annular alphasynuclein protofibrils are produced when spherical protofibrils are incubated in solution or bound to brain-derived membranes.

Architecture of the Alzheimer's A beta P ion channel pore.

Atomic force microscopy reveals defects within mica supported lipid bilayers induced by the amyloidogenic human amylin peptide.

B i o p h y s i c s o f p r o t e i n m i s f o l d i n g 070605 Oratieboekje Subramaniam

B i o p h y s i c s o f p r o t e i n m i s f o l d i n g 070605 Oratieboekje Subramaniam 14-06-2007 08:54 Pagina 3334 B i o p h y s i c s o f p r o t e i n m i s f o l d i n g 070605

biochemistry of Parkinson's disease.

Biophysical properties of the synucleins and their propensities to fibrillate - Inhibition of alpha-synuclein assembly by beta- and gamma-synucleins.

Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers.

Central Dogma of Molecular Biology.

Characterization of a novel protein regulated during the critical period for song learning in the zebra finch. Neuron 15:361-372. B i o p h y s i c s o f p r o t e i n m i s f o l d i n g 070605 Oratieboekje Subramaniam

Characterization of the nanoscale properties of individual amyloid fibrils.

Cholesterol, a modulator of membrane-associated Abeta-fibrillogenesis and neurotoxicity.

Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis.

Comparison of structure and dynamics of micelle-bound human alpha-synuclein and Parkinson disease variants. J Biol Chem 280:43179-43187. B i o p h y s i c s o f p r o t e i n m i s f o l d i n g 070605 Oratieboekje Subramaniam

Cryo-electron microscopy structure of an SH3 amyloid fibril and model of the molecular packing. Embo J 18:815-821. B i o p h y s i c s o f p r o t e i n m i s f o l d i n g 070605 Oratieboekje Subramaniam

Curli Biogenesis and Function. Annu Rev Microbiol.

de Yebenes. 2004.The new mutation, E46K, of alphasynuclein causes Parkinson and Lewy body dementia.

Dependence of alpha-synuclein aggregate morphology on solution conditions.

Designing conditions for in vitro formation of amyloid protofilaments and fibrils.

Early events in insulin fibrillization studied by time-lapse atomic force microscopy.

Enhancement of protein crystal nucleation by critical density fluctuations.

Evidence for a partially folded intermediate in alpha-synuclein fibril formation.

Impaired dopamine storage resulting from alpha-synuclein mutations may contribute to the pathogenesis of Parkinson's disease.

Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases.

Intrinsic disorder and functional proteomics.

Islet amyloid polypeptide-induced membrane leakage involves uptake of lipids by forming amyloid fibers.

Kinetic theory of fibrillogenesis of amyloid beta-protein.

Lewy bodies.

Membrane Permeabilization: A Common Mechanism in Protein Misfolding Diseases. Sci. Aging Knowl.

Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein - A possible molecular link between Parkinson's disease and heavy metal exposure.

Molecular conformation of a peptide fragment of transthyretin in an amyloid fibril.

Molecular crowding accelerates fibrillization of alpha-synuclein: could an increase in the cytoplasmic protein concentration induce Parkinson's disease?

Molecular structure of amyloid fibrils: insights from solid-state NMR. Q Rev Biophys:1-55.

Molecular-level secondary structure, polymorphism, and dynamics of full-length alpha-synuclein fibrils studied by solid-state NMR.

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease.

NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded.

Nanomedicine and Protein Misfolding Diseases.

Natively unfolded proteins: a point where biology waits for physics.

Neurodegenerative disease: amyloid pores from pathogenic mutations.

On Protein Synthesis.

On the nucleation and growth of amyloid beta-protein fibrils: detection of nuclei and quantitation of rate constants.

Packing density and structural heterogeneity of insulin amyloid fibrils measured by AFM nanoindentation.

permeabilization by protofibrillar alphasynuclein: implications for the pathogenesis and treatment of Parkinson's disease.

Polycation-induced oligomerization and accelerated fibrillation of human alpha-synuclein in vitro.

Protein aggregation and its consequences for human disease.

Protein aggregation and its inhibition in biopharmaceutics.

Protein drug stability: a formulation challenge.

Protein fibrils in nature can enhance amyloid protein A amyloidosis in mice: Cross-seeding as a disease mechanism.

Protein misfolding, functional amyloid, and human disease.

Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders.

Quantitative morphological analysis reveals ultrastructural diversity of amyloid fibrils from alpha-synuclein mutants.

Rapid self-assembly of alpha-synuclein observed by in situ atomic force microscopy.

Reversible mechanical unzipping of amyloid beta-fibrils.

Rifampicin inhibits alpha-synuclein fibrillation and disaggregates fibrils.

Role of Escherichia coli curli operons in directing amyloid fiber formation.

Self-propagating, molecular-level polymorphism in Alzheimer's beta-amyloid fibrils.

Snaring the function of alpha-synuclein.

Solid-state NMR as a probe of amyloid structure.

Synucleins in synaptic plasticity and neurodegenerative disorders.

What does it mean to be natively unfolded?

Zeroing in on the pathogenic form of alpha-synuclein and its mechanism of neurotoxicity in Parkinson's disease.

http://purl.utwente.nl/publications/58042

Biophysics of protein misfolding

Abstract

Similar works

Full text

Available Versions

University of Twente Research Information

NARCIS